In that respect, interestingly, in the prophylactic model of Stark et al. even if a single dose of vaccine triggered a lower frequency of antigen-specific CD8 T cells than multiple doses, the late tumor protection was similar (tumor challenge on day 323). This evidence concerns the gene CD8A and neoplasm.